Search for: "Generic Pharmaceutical Services, Inc." Results 281 - 300 of 1,028
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2017, 7:02 am by Fraud Fighters
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
22 Aug 2017, 5:00 am by Donovan Gibbons
” In response, the Shareholders argued that the sales of tobacco products by pharmaceutical companies constituted an exception to this general rule as implicating a significant policy issues. [read post]
4 Jun 2017, 12:27 pm by Stuart Kaplow
This law firm has provided hazardous waste management services for retailers, including in the pharmaceutical industry, as well as a host of other businesses from landscapers to medical offices, ranging from solid waste management plans (that can qualify for LEED credits), to waste characterization, training programs, and regulatory notifications. [read post]
1 May 2017, 10:58 am by Lawrence B. Ebert
:Helsinn brought suit against Teva PharmaceuticalsUSA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
20 Apr 2017, 8:23 am by Elizabeth Kruska
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
16 Mar 2017, 5:03 pm by Francis Pileggi
Calistoga Pharmaceuticals, Inc. was purchased by Gilead Sciences, Inc. in 2011 pursuant to a merger agreement which included milestone payments based on certain triggers. [read post]
“Specialty drugs” are a fast growing sector of the pharmaceutical industry and are predicated to represent 50 percent of drug expenditures in the United States by 2020.[1] Specialty drugs are typically dispensed by specialty pharmacies. [read post]
9 Feb 2017, 6:14 pm by Steven Boutwell
By William Kolarik The New Jersey Tax Court’s opinion in Elan Pharmaceuticals, Inc. v. [read post]
2 Feb 2017, 9:53 am by Kevin LaCroix
Prior to his judicial service, Judge Gorsuch also wrote an amicus brief for the United States Chamber of Commerce in Dura Pharmaceuticals, Inc. v. [read post]
2 Feb 2017, 9:53 am by Kevin LaCroix
Prior to his judicial service, Judge Gorsuch also wrote an amicus brief for the United States Chamber of Commerce in Dura Pharmaceuticals, Inc. v. [read post]
18 Jan 2017, 1:28 pm
 Staying with patents, as IPKat member Neil Wilkof discusses on IP Finance the challenges faced by the world’s largest generic drug company, Teva Pharmaceutical Industries Ltd (based in Israel), but whose most successful product in recent years has been the proprietary drug COPAXONE. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
5 Jan 2017, 11:37 am by Heidi A. Nadel
Allied had a contract with Imperial to provide such services, and the contract contained successive, three-year, auto-renewed terms and a liquidated damages clause. [read post]
5 Jan 2017, 11:37 am by Heidi A. Nadel
Allied had a contract with Imperial to provide such services, and the contract contained successive, three-year, auto-renewed terms and a liquidated damages clause. [read post]